Description
A SARM (Ki = 5.01 nM); an androgen receptor partial agonist (EC50 = 1.58 nM in a luciferase assay); selective for the androgen receptor over a panel of 47 additional human nuclear receptors at 10 µM; inhibits dihydroxytestosterone-induced proliferation of LNCaP prostate cancer cells at 0.1 and 1 µM; reduces plasma luteinizing hormone levels and increases levator ani muscle weight in castrated rats at 3, 10, and 30 mg/kg; exhibits smaller increases in prostate gland and seminal vesicle weight compared with testosterone in the same model
Formal name: 4-[(3-endo)-3-hydroxy-8-azabicyclo[3.2.1]oct-8-yl]-1-naphthalenecarbonitrile
Synonyms:
Molecular weight: 278.4
CAS: 870888-46-3
Purity: ≥98%
Formulation: A solid